Atlas Trials

Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010

Clinical trial NCT00175019 · COMPLETED

Trial details

NCT number
NCT00175019
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Gout
Start date
2003-07-01
Primary completion
2007-02-01
Enrollment
1086

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.